Combining a breast cancer patient's clinical characteristics with a genomic profile of her tumor may provide important information for predicting an individual patient's prognosis and accurately guiding treatment options, according to a new study led by researchers in the Duke Comprehensive Cancer Center (DCCC) and Duke's Institute for Genome Sciences & Policy (IGSP). The findings appear in the April 2, 2008 issue of the Journal of the American Medical Association.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.